Clinical relevance of TCI score-based refinement of conditioning intensity in cord blood transplantation for myelodysplastic syndrome.

Authors

Machiko Fujioka, Hidehiro Itonaga, Yasushi Miyazaki, Yoshimitsu Shimomura, Shigesaburo Miyakoshi, Shinichiro Machida, Naoyuki Uchida, Takeshi Maeda, Masatsugu Tanaka, Yasufumi Uehara, Satoshi Takahashi, Noriko Doki, Naoyuki Anzai, Mamiko Sakata-Yanagimoto, Toshimitsu Ueki, Masashi Sawa, Yoshiko Matsuhashi, Yuta Katayama, Fumihiko Ishimaru, Makoto Onizuka, Junya Kanda, Yoshiko Atsuta, Ken Ishiyama, adult MDS working group of the Japanese Society for Transplantation and Cellular Therapy

Published in

Transplantation and cellular therapy. Aug 15, 2026. Epub Aug 15, 2026.

Abstract

Cord blood transplantation (CBT) is an alternative donor strategy for patients with myelodysplastic syndrome (MDS). To clarify the impact of the Transplant Conditioning Intensity (TCI) score, we examined 1127 patients with de novo MDS who underwent CBT between 2008 and 2022, using a nationwide registry database. Patients were stratified into three age groups: <50 years (Younger group, n=256), 50-64 years (Middle group, n=545), and 65-74 years (Older group, n=326). In the Older group, the multivariate analysis revealed that TCI score of 4.5-5.0 correlated with higher overall mortality than TCI score of 3.5-4.0 (HR 1.61, 95% CI 1.02-2.49, p=0.032). In the Middle group, TCI score of 4.5-5.0 was associated with lower relapse incidence than TCI score of 3.5-4.0 (HR 0.64, 95% CI 0.45-0.91, p=0.014), but did not have any significant impact on overall mortality. In the Younger group, no significant difference was observed in overall mortality, relapse incidence, and non-relapse mortality. Collectively, these findings support the utility of TCI score-based conditioning stratification as a practical framework for guiding age-adapted conditioning regimen selection in patients with de novo MDS undergoing CBT.

PMID:
42603591
Bibliographic data and abstract were imported from PubMed on 16 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.